410867006: Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing histamine receptor antagonist (product)\...

\Product containing histamine H1 receptor antagonist (product)\Product containing clemastine (medicinal product)\...

\Product containing clemastine in oral dose form (medicinal product form)\Clemastine- and phenylpropanolamine-containing product in oral dose form\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)

\Product containing clemastine and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)\Clemastine and paracetamol and phenylpropanolamine only product\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing clemastine and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing clemastine and phenylpropanolamine (medicinal product)\Clemastine- and phenylpropanolamine-containing product in oral dose form\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)

\Ethanolamine derivative histamine receptor antagonist product\Product containing clemastine (medicinal product)\...

\Product containing clemastine in oral dose form (medicinal product form)\Clemastine- and phenylpropanolamine-containing product in oral dose form\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)

\Product containing clemastine and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)\Clemastine and paracetamol and phenylpropanolamine only product\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing clemastine and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing clemastine and phenylpropanolamine (medicinal product)\Clemastine- and phenylpropanolamine-containing product in oral dose form\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)

\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing ethanolamine and/or ethanolamine derivative (product)\Ethanolamine derivative histamine receptor antagonist product\Product containing clemastine (medicinal product)\Product containing clemastine in oral dose form (medicinal product form)\Clemastine- and phenylpropanolamine-containing product in oral dose form\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing ethanolamine and/or ethanolamine derivative (product)\Ethanolamine derivative histamine receptor antagonist product\Product containing clemastine (medicinal product)\Product containing clemastine and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)\Clemastine and paracetamol and phenylpropanolamine only product\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing ethanolamine and/or ethanolamine derivative (product)\Ethanolamine derivative histamine receptor antagonist product\Product containing clemastine (medicinal product)\Product containing clemastine and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing ethanolamine and/or ethanolamine derivative (product)\Ethanolamine derivative histamine receptor antagonist product\Product containing clemastine (medicinal product)\Product containing clemastine and phenylpropanolamine (medicinal product)\Clemastine- and phenylpropanolamine-containing product in oral dose form\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing paracetamol (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)\Clemastine and paracetamol and phenylpropanolamine only product\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing paracetamol (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol in oral dose form (medicinal product form)\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing phenylpropanolamine (medicinal product)\Phenylpropanolamine-containing product in oral dose form\Clemastine- and phenylpropanolamine-containing product in oral dose form\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing phenylpropanolamine (medicinal product)\Product containing clemastine and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)\Clemastine and paracetamol and phenylpropanolamine only product\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing phenylpropanolamine (medicinal product)\Product containing clemastine and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing phenylpropanolamine (medicinal product)\Product containing clemastine and phenylpropanolamine (medicinal product)\Clemastine- and phenylpropanolamine-containing product in oral dose form\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Phenol structure-containing product\Product containing paracetamol (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)\Clemastine and paracetamol and phenylpropanolamine only product\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Phenol structure-containing product\Product containing paracetamol (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Phenol structure-containing product\Product containing paracetamol (medicinal product)\Product containing paracetamol in oral dose form (medicinal product form)\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing alcohol (product)\Product containing phenylpropanolamine (medicinal product)\Phenylpropanolamine-containing product in oral dose form\Clemastine- and phenylpropanolamine-containing product in oral dose form\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing alcohol (product)\Product containing phenylpropanolamine (medicinal product)\Product containing clemastine and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)\Clemastine and paracetamol and phenylpropanolamine only product\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing alcohol (product)\Product containing phenylpropanolamine (medicinal product)\Product containing clemastine and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing alcohol (product)\Product containing phenylpropanolamine (medicinal product)\Product containing clemastine and phenylpropanolamine (medicinal product)\Clemastine- and phenylpropanolamine-containing product in oral dose form\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)

\Product manufactured as oral dose form (product)\Phenylpropanolamine-containing product in oral dose form\Clemastine- and phenylpropanolamine-containing product in oral dose form\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Product manufactured as oral dose form (product)\Product containing clemastine in oral dose form (medicinal product form)\Clemastine- and phenylpropanolamine-containing product in oral dose form\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Product manufactured as oral dose form (product)\Product containing paracetamol in oral dose form (medicinal product form)\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)

\Product containing autonomic agent (product)\Product containing sympathomimetic (product)\Product containing phenylpropanolamine (medicinal product)\...

\Phenylpropanolamine-containing product in oral dose form\Clemastine- and phenylpropanolamine-containing product in oral dose form\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)

\Product containing clemastine and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)\Clemastine and paracetamol and phenylpropanolamine only product\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing clemastine and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product)\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing clemastine and phenylpropanolamine (medicinal product)\Clemastine- and phenylpropanolamine-containing product in oral dose form\Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)\Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3699530010 Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3699532019 Clemastine fumarate 335 microgram and paracetamol 500 mg and phenylpropanolamine 30 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3699533012 Acetaminophen 500 mg and clemastine fumarate 335 microgram and phenylpropanolamine 30 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Product containing clemastine fumarate and paracetamol and phenylpropanolamine	false	Inferred relationship	Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Paracetamol	false	Inferred relationship	Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Phenylpropanolamine (substance)	false	Inferred relationship	Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Clemastine fumarate	false	Inferred relationship	Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Ethanolamine	false	Inferred relationship	Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Has manufactured dose form	A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition.	false	Inferred relationship	Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Cardiovascular agent (substance)	false	Inferred relationship	Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Has manufactured dose form	Oral tablet	true	Inferred relationship	Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Product containing paracetamol in oral dose form (medicinal product form)	false	Inferred relationship	Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Phenylpropanolamine (substance)	false	Inferred relationship	Some	1
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Phenylpropanolamine (substance)	true	Inferred relationship	Some	1
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	30	false	Inferred relationship	Some	1
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	1
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	un	false	Inferred relationship	Some	1
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	1
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Paracetamol	false	Inferred relationship	Some	2
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Paracetamol	true	Inferred relationship	Some	2
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	500	false	Inferred relationship	Some	2
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	2
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	un	false	Inferred relationship	Some	2
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	2
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Clemastine fumarate	false	Inferred relationship	Some	3
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Clemastine fumarate	true	Inferred relationship	Some	3
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	0.335	false	Inferred relationship	Some	3
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the numerator unit for the presentation strength of a product.	mg	false	Inferred relationship	Some	3
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	un	false	Inferred relationship	Some	3
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	3
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Paracetamol	false	Inferred relationship	Some	3
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	500	false	Inferred relationship	Some	3
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Phenylpropanolamine (substance)	false	Inferred relationship	Some	2
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	30	false	Inferred relationship	Some	2
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Clemastine fumarate	false	Inferred relationship	Some	1
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Phenylpropanolamine (substance)	false	Inferred relationship	Some	2
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	Tablet (unit of presentation)	true	Inferred relationship	Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Paracetamol	false	Inferred relationship	Some	3
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Clemastine fumarate	false	Inferred relationship	Some	1
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)	false	Inferred relationship	Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	trois	false	Inferred relationship	Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the numerator unit for the presentation strength of a product.	mcg	false	Inferred relationship	Some	1
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	335	false	Inferred relationship	Some	1
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form)	true	Inferred relationship	Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Clemastine fumarate	true	Inferred relationship	Some	3
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Paracetamol	true	Inferred relationship	Some	2
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the numerator unit for the presentation strength of a product.	mcg	true	Inferred relationship	Some	3
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Phenylpropanolamine (substance)	true	Inferred relationship	Some	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3699530010	Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3699532019	Clemastine fumarate 335 microgram and paracetamol 500 mg and phenylpropanolamine 30 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3699533012	Acetaminophen 500 mg and clemastine fumarate 335 microgram and phenylpropanolamine 30 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core